Jyoti CNC made its debut on Dalal Street in January last year. This remarkable rally in share prices can be attributed to the company’s strong financial performance in recent quarters ...

The Company advises the users to check with duly registered and qualified advisors before taking any investment decision. The Company does not guarantee the accuracy, adequacy or completeness of ...

The IPO of Jyoti CNC will open for public subscription on January 9 and end on January 11. The anchor book of the offer will be opened for a day on January 8, the company announced. Investors can ...

Jyoti CNC Automation Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Company''s Offical will interact with Analyst / Investors at Equirus Roadshow on March 10, 2025 ...

No Data For Bulk Deal. *Involves transaction of at least 0.5% of the listed shares of a company. Jyoti CNC Automation Ltd share price was down by -5.47% from the previous closing price of ₹983.75.

Industrials stocks were trading in the positive zone, with the BSE Industrials index rising 93.79 points or 0.8% at 11808.7 at 09:46 IST.

IST on BSE, a 4.01 fold spurt over two-week average daily volume of 1446 shares Jyoti CNC Automation Ltd, India Cements Ltd, eClerx Services Ltd, ICICI Lombard General Insurance Company Ltd are among ...

Jyoti CNC IPO: While strong brand presence and robust market share are undeniable, the financial concerns and hefty valuation necessitate a cautious approach Jyoti CNC Automation makes decent ...

Jyoti CNC Automation Ltd's Revenue of 16.212 B ranks in the 62.3% percentile for the Sector. The following table provides additional summary stats: ...

At the end of the June quarter, Paresh owned 1.12% of Sun Pharma Advanced Research, while his brother Vijay owned 1.13% of the company.

The Exchange has sought clarification from Jyoti CNC Automation Ltd on March 11, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant ...

At the end of the June quarter, Paresh owned 1.12% of Sun Pharma Advanced Research, while his brother Vijay owned 1.13% of the company.